In addition, high level of CXCL9+ tumor-associated macrophages (TAMs) was associated with favorable prognosis, implying that this subpopulation of macrophage may activate anti-tumor immune responses (Bill et al., 2023). This evidence concerns the gene CXCL9 and neoplasm.